SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950005-02-000446
Filing Date
2002-04-19
Accepted
2002-04-19 00:00:00
Documents
3
Period of Report
2002-04-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE 14A p15293_def14a.txt DEF 14A 107485
3 STOCK OPTION PLAN p15293_exoption-plan.txt EX-99 21859
4 EQUITY INCENTIVE PLAN p15293_exincentive-plan.txt EX-99 56319
  Complete submission text file 0000950005-02-000446.txt   187443
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26372 | Film No.: 02615075
SIC: 2834 Pharmaceutical Preparations